Does RITUXIMAB Cause Hepatic cancer? 49 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Hepatic cancer have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
49
Reports of Hepatic cancer with RITUXIMAB
0.0%
of all RITUXIMAB reports
17
Deaths
15
Hospitalizations
How Dangerous Is Hepatic cancer From RITUXIMAB?
Of the 49 reports, 17 (34.7%) resulted in death, 15 (30.6%) required hospitalization, and 6 (12.2%) were considered life-threatening.
Is Hepatic cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Hepatic cancer?
RANITIDINE (17,818)
SORAFENIB (228)
LEDIPASVIR\SOFOSBUVIR (197)
ADALIMUMAB (193)
RIBAVIRIN (190)
VALSARTAN (165)
RIFAXIMIN (151)
SOFOSBUVIR (141)
ETANERCEPT (97)
ENTECAVIR (94)
Which RITUXIMAB Alternatives Have Lower Hepatic cancer Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE